Essex Investment Management Co. LLC Sells 197,165 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Essex Investment Management Co. LLC trimmed its holdings in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 14.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,212,964 shares of the company’s stock after selling 197,165 shares during the quarter. Essex Investment Management Co. LLC owned about 1.43% of Stereotaxis worth $2,766,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of STXS. SG Americas Securities LLC lifted its position in shares of Stereotaxis by 39.2% during the 4th quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock valued at $60,000 after acquiring an additional 7,417 shares during the period. Jane Street Group LLC lifted its position in Stereotaxis by 26.9% during the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after purchasing an additional 6,313 shares during the period. Raymond James Financial Inc. acquired a new stake in Stereotaxis during the fourth quarter worth about $101,000. Wealth Effects LLC grew its stake in Stereotaxis by 11.7% during the fourth quarter. Wealth Effects LLC now owns 86,060 shares of the company’s stock worth $196,000 after buying an additional 9,000 shares in the last quarter. Finally, Barclays PLC increased its holdings in Stereotaxis by 449.9% in the 3rd quarter. Barclays PLC now owns 101,953 shares of the company’s stock valued at $208,000 after buying an additional 83,412 shares during the period. Institutional investors and hedge funds own 45.35% of the company’s stock.

Stereotaxis Price Performance

Stereotaxis stock opened at $1.87 on Monday. Stereotaxis, Inc. has a 52 week low of $1.66 and a 52 week high of $3.29. The firm has a market cap of $158.45 million, a PE ratio of -6.68 and a beta of 1.54. The stock’s fifty day simple moving average is $2.27.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.